Morgan Stanley’s PHI, Inc. PHII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1
Closed 6941
2018
Q4
$0 Sell
1
-300
-100% -$1.88K ﹤0.01% 6988
2018
Q3
$3K Buy
+301
New +$2.72K ﹤0.01% 6548
2018
Q2
Sell
-1
Closed 6973
2018
Q1
$0 Hold
1
﹤0.01% 6910
2017
Q4
$0 Buy
+1
New +$12 ﹤0.01% 6894
2017
Q1
Sell
-200
Closed -$4K 6767
2016
Q4
$4K Hold
200
﹤0.01% 6322
2016
Q3
$4K Hold
200
﹤0.01% 6304
2016
Q2
$3K Sell
200
-4
-2% -$76 ﹤0.01% 6347
2016
Q1
$4K Sell
204
-1
-0.5% -$18 ﹤0.01% 6349
2015
Q4
$4K Buy
205
+5
+3% +$99 ﹤0.01% 6440
2015
Q3
$4K Buy
200
+195
+3,900% +$5.23K ﹤0.01% 6439
2015
Q2
$0 Hold
5
﹤0.01% 7022
2015
Q1
$0 Hold
5
﹤0.01% 6965
2014
Q4
$0 Hold
5
﹤0.01% 6995
2014
Q3
$0 Hold
5
﹤0.01% 6934
2014
Q2
$0 Hold
5
﹤0.01% 6861
2014
Q1
$0 Buy
+5
New +$194 ﹤0.01% 6790

Morgan Stanley's PHII Position: Q1 2019 in Review

Morgan Stanley sold out of PHI, Inc. (PHII) in Q1 2019, closing a stake of 1 share.

Morgan Stanley first reported a position in PHII in Q1 2014 and held it in 16 quarters. The position peaked at $4K in Q4 2016. 0 funds tracked by Wall St. Rank hold PHII as of Q1 2019.

  • Morgan Stanley reported no remaining PHI, Inc. position as of Q1 2019 after selling out during the quarter.
  • Morgan Stanley sold 1 PHI, Inc. share in Q1 2019.
  • Morgan Stanley first reported a position in PHI, Inc. in Q1 2014 and held it in 16 quarters.
  • Morgan Stanley's PHI, Inc. position peaked at $4K in Q4 2016.
  • 0 funds tracked by Wall St. Rank held PHI, Inc. as of Q1 2019.

Based on Morgan Stanley's 13F filing for Q1 2019, filed 15 May 2019.